Physician profile
Marc E Goldberg
NPI 1447256714
$695.02
in general payments reported to CMS, 2019-2025
16 companies · $46.73 in 2025
The $46.73 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $50.55 · 2021: $43.73 · 2022: $181 · 2023: $92.39 · 2024: $159 · 2025: $46.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $297.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $119.54 | 2022 | |
| Treace Medical Concepts, INC. | $81.21 | 2023-2024 | |
| Zimmer Biomet Holdings, INC. | $77.39 | 2019-2020 | |
| Smith+Nephew, INC. | $59.84 | 2019-2021 | |
| Organogenesis INC. | $57.84 | 2022-2023 | Puraply |
| Paratek Pharmaceuticals, INC. | $44.52 | 2024 | Nuzyra |
| Musculoskeletal Transplant Foundation INC. | $44.46 | 2019-2024 | |
| Horizon Therapeutics Plc | $44.19 | 2019-2023 | Krystexxa |
| Nevro Corp. | $33.63 | 2022 | |
| Averitas Pharma INC. | $27.89 | 2025 | Qutenza |
| Kerecis Limited | $25.02 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Merck Sharp & Dohme LLC | $22.93 | 2019 | |
| Linvatec Corporation | $18.84 | 2025 | Biobrace 23mm, In2bones USA, Hercules Suture Anchor System |
| Sebela Pharmaceuticals INC. | $14.18 | 2022 | |
| Arthrosurface Incorporated | $11.96 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $11.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Goldberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.